Conventional quercetin disperses poorly and can be slow to dissolve. Q-QUERALIS is designed to address that delivery challenge.

PQNS Quercetin vs standard quercetin — total quercetin concentration over the first 12 hours after dose.

Quercetin is a plant flavonoid studied across several areas of health. Explore an engineered delivery approach for these product concepts.
Oxidative-stress pathways and cellular protection are central areas of quercetin research.
Research spans vascular biology and the regulation of glucose and lipid metabolism.
Quercetin is studied for its role in supporting normal immune-system function.
Research explores quercetin's role in supporting active, healthy-aging lifestyles.
These concepts draw on quercetin research, not established Q-Queralis health benefits. Product-specific substantiation is required.
Increasing the amount of quercetin alone may not resolve its delivery limitations. Q-QUERALIS is designed to improve dispersion and availability for absorption, giving brands an ingredient proposition built around engineered delivery.
Quercetin associated with phospholipids, designed for improved oral delivery.

Conventional quercetin disperses poorly and can be slow to dissolve. Q-QUERALIS is designed to address that delivery challenge.
5.5× peak concentration (Cmax), 5.8× exposure over 0–12 h (AUC), and a modeled concentration of 50.8 vs 4.79 at 12 h — PQNS vs standard quercetin. Approximately 5.5× higher peak levels, prolonged circulation, and greater bioavailability.
QuanticSphere™ is a Phytosome Quantum Nano Sphere: quercetin associated with phospholipids, designed for improved oral delivery. Particle size 184.4 nm (DLS Z-average), surface charge +46.0 mV.
Antioxidant & cellular protection, cardiometabolic health, immune health, and healthy aging & active lifestyles. These concepts draw on quercetin research, not established Q-Queralis health benefits — product-specific substantiation is required.
Facility: NSF/ANSI 455-2 certified GMP, FSSC 22000, ISO 9001/14001/45001. Regulatory: 21 CFR Part 111, Halal Certified. Dissolution: approximately 95–100% release, batch-consistent. IP: QuanticSphere™ PQNS, patent pending 202521095813.
Share your formulation requirements and our team can walk you through the full Q-Queralis clinical dossier, supply format and technical specifications.
Talk to a SpecialistEnter your email to download the full PDF with clinical data, specifications and formulation details.